Daunocyte 20 mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Daunocyte 20 mg Injection contains daunorubicin, an anthracycline cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of leukemia (blood cancer). It is described as interfering with the growth of cancer cells by damaging their DNA, which eventually stops their growth and multiplication. It is given only by a professional doctor, per the dosage and interval set by them, and must not be self-administered.

Active ingredient
Daunorubicin (as hydrochloride)
Strength
20 mg
Dosage form
Powder / solution for injection
Therapeutic class
Anthracycline (cytotoxic antibiotic, antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of leukemia (blood cancer)
  • Its labelling also lists a range of other cancers
  • Described as damaging the DNA of cancer cells to stop their growth and multiplication
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given only by a professional doctor, per the dosage and interval set by them; not to be self-administered
  • The dose, interval, blood tests, and duration are decided by the doctor and should be followed diligently
  • Results may take months to show, so patience is advised

Described Side Effects

Commonly described side effects include:

  • Nausea and vomiting
  • Low blood platelets
  • Abdominal pain
  • Loss of appetite
  • Decreased white blood cell count
  • Hair loss
  • Fever and chills
  • Fatigue
  • Anaemia
  • Diarrhoea
  • Breathing problems

These are described as commonly temporary. They should be reported to the doctor if they persist.

Precautions

  • Alcohol should be avoided at all costs
  • A complete medical history should be shared, with the doctor told about kidney or liver issues or any allergies
  • Pregnancy should be avoided as it can harm the baby; it should not be taken if already pregnant or breastfeeding

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains daunorubicin and is used for the treatment of leukemia (blood cancer). SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given only by a professional doctor, per the dosage and interval set by them, and never self-administered.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services